Header Logo

Connection

Frederick Raal to Hep G2 Cells

This is a "connection" page, showing publications Frederick Raal has written about Hep G2 Cells.
Connection Strength

0,133
  1. PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's role. J Lipid Res. 2016 06; 57(6):1086-96.
    View in: PubMed
    Score: 0,133
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.